Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BEAM Beam Therapeutics, Inc.

盘前交易 09-22 08:38:06 EDT

25.26

+0.31

+1.24%

盘前25.47

+0.21+0.83%

08:38 EDT

最高25.66	最低24.83	成交量170.39万
今开25.45	昨收24.95	日振幅3.33%
总市值26.09亿	流通市值23.14亿	总股本1.03亿
成交额4,287万	换手率1.86%	流通股本9,160万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BEAM","market":"US","secType":"STK","nameCN":"Beam Therapeutics, Inc.","latestPrice":25.26,"timestamp":1790020800000,"preClose":24.95,"halted":0,"volume":1703948,"hourTrading":{"tag":"盘前","latestPrice":25.47,"preClose":25.26,"latestTime":"08:38 EDT","volume":4352,"amount":110482.931456,"timestamp":1790080684706,"change":0.21,"changeRate":0.008314,"amplitude":0.015439},"delay":0,"changeRate":0.01242484969939889,"floatShares":91603300,"shares":103287665,"eps":-0.837623,"marketStatus":"盘前交易","change":0.31,"latestTime":"09-22 08:38:06 EDT","open":25.45,"high":25.66,"low":24.83,"amount":42873856.930936,"amplitude":0.033267,"askPrice":26,"askSize":100,"bidPrice":25.31,"bidSize":21,"shortable":3,"etf":0,"ttmEps":-0.837623,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790083800000},"marketStatusCode":1,"adr":0,"listingDate":1580965200000,"exchange":"NASDAQ","adjPreClose":25.26,"preHourTrading":{"tag":"盘前","latestPrice":25.47,"preClose":25.26,"latestTime":"08:38 EDT","volume":4352,"amount":110482.931456,"timestamp":1790080684706,"change":0.21,"changeRate":0.008314,"amplitude":0.015439},"postHourTrading":{"tag":"盘后","latestPrice":25.0558,"preClose":25.26,"latestTime":"19:54 EDT","volume":23421,"amount":591026.0563,"timestamp":1790034855918,"change":-0.2042,"changeRate":-0.008084,"amplitude":0.012827},"volumeRatio":0.8051472783905268,"impliedVol":0.5925,"impliedVolPercentile":0.184},"requestUrl":"/m/hq/s/BEAM","defaultTab":"news","newsList":[{"id":"1133255075","title":"Beam Therapeutics在欧洲呼吸学会2026年大会上公布Beam-302治疗α-1抗胰蛋白酶缺乏症1/2期临床试验最新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1133255075","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133255075?lang=zh_cn&edition=full","pubTime":"2026-09-08 18:01","pubTimestamp":1788861674,"startTime":"0","endTime":"0","summary":"Beam Therapeutics于欧洲呼吸学会2026年大会上，公布了Beam-302在α-1抗胰蛋白酶缺乏症治疗领域1/2期临床试验的最新临床数据。在大会现场，Beam Therapeutics的研发团队详细阐述了受试者的生物标志物变化、肺功能指标改善趋势以及药物耐受性情况。公司方面表示，这些更新数据进一步验证了Beam-302的潜在疾病修饰作用，并支持其后续临床开发路径的推进。业内分析人士指出，这一进展不仅关乎Beam药业自身管线价值的重估，也可能对AATD现有标准治疗格局构成远期挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4505","BK4611","BK4556","BK4139","LU1861559042.SGD","BK4535","LU1861558580.USD","BEAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159265220","title":"Beam Therapeutics公布2026年第二季度财务业绩，并宣布在α-1抗胰蛋白酶缺乏症（AATD）领域Beam-302试验全球关键队列中首例患者完成给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1159265220","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159265220?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:01","pubTimestamp":1785841273,"startTime":"0","endTime":"0","summary":"Beam Therapeutics（纳斯达克股票代码：BEAM）今日披露其2026年第二季度的财务表现，同时对外宣布，其针对α-1抗胰蛋白酶缺乏症（AATD）的研究性疗法Beam-302，已在全球关键性临床试验队列中完成首例患者给药。这一里程碑事件，标志着该候选药物在开发进程中迈出了至关重要的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4611","BK4556","BK4588","BK4139","BK4505","LU1861559042.SGD","BK4585","BEAM","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651443872","title":"木头姐日内调仓分化 持续加码航天军工 减持农业基因标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2651443872","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651443872?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:57","pubTimestamp":1784195848,"startTime":"0","endTime":"0","summary":"当日资金投入力度最大的标的为太空探索技术公司 ，多只 ARK 系 ETF 合计斥资 1670 万美元，买入 122807 股，对应成交均价约 135.99 美元，机构持续加大航天赛道配置比重。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302638","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKB","161024","MADE","VEGI","BCCC","BETH","BTFX","IDNA","BITB","BTRN","DFII","CBXA","QBF","FTAG","SNK","SPCG","TXG","ARKW","SHLD","BEAM","CBXJ","SPCH","BFAP","SPCF","SPAL","DE","ARKQ","FMED","SPCU","HWAY","ARKK","KTOS","KTUP","BTCL","ARKX","TWST","ARKG","WDNA","SPCX","LOFF","GNOM","HODL","159041","KROP","BITU","SARK","CBTY","ARKF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645819136","title":"基因编辑概念普升 安捷伦科技(A)领涨4.21% 机构指美国FDA相关疗法审评新规利好相关标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2645819136","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645819136?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:21","pubTimestamp":1782310862,"startTime":"0","endTime":"0","summary":"金吾财讯 | 美股基因编辑概念普升，截至发稿，安捷伦科技 (A) 涨 4.21%，Beam Therapeutics (BEAM) 涨 3.55%，Intellia Therapeutics (NTLA) 涨 2.95%，Editas Medicine (EDIT) 涨 2.17%，福泰制药 (VRTX) 涨 1.28%。消息面上，建银国际新近研究认为，美国FDA近期发布了基因编辑疗法审评新规，允许药企在提供充分科学可比性论证的前提下，引用“先验知识”或既往成熟研究数据以加速研发，此举这标志着基因编辑疗法审评思路的重要转变，直接利好拥有相关技术平台的企业。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/NDViNTE0MThlOGIzNGVjYjVmZmFmNTJlOTIxNzAyOTY1ODYyNw==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDViNTE0MThlOGIzNGVjYjVmZmFmNTJlOTIxNzAyOTY1ODYyNw==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301875","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","LU2324357040.USD","BK4533","BK4139","IE00BN0W2W23.USD","BK4567","IE00BJJMRZ35.SGD","LABU","IE00B19Z3581.USD","LU1674673691.USD","LU2092937221.SGD","LU2362540622.SGD","LU2089279066.USD","BEAM","LU2413666699.HKD","LU0432979614.USD","NTLA","LU0320765992.SGD","BK4588","LU2462157665.USD","SG9999013999.USD","LU0058720904.USD","BK4505","LU0109394709.USD","EDIT","IE00B894F039.SGD","A","LU1035775433.USD","LU2041044095.USD","LU0889565916.HKD","IE00BZ9MQY76.HKD","VRTX","LU0417517546.SGD","LU1861559042.SGD","LU1585245621.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2236285917.USD","IE00B19Z9Z06.USD","LU2362541273.HKD","LU2229751404.USD","LU1861558580.USD","LU0234570918.USD","SG9999001176.SGD","LU0079474960.USD","BK4121","BK4611","LU0256863811.USD","SGXZ57979304.SGD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168068951","title":"Beam Therapeutics宣布其用于治疗苯丙酮尿症的在研新药Beam-304获美国FDA临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=1168068951","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168068951?lang=zh_cn&edition=full","pubTime":"2026-06-18 19:02","pubTimestamp":1781780553,"startTime":"0","endTime":"0","summary":"Beam Therapeutics, Inc. 宣布，其用于治疗苯丙酮尿症的在研新药Beam-304，其新药临床试验申请已获得美国食品和药物管理局的许可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","LU1861559042.SGD","BK4139","BK4535","BEAM","LU1861558580.USD","BK4611","BK4505","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518220291","title":"Beam Therapeutics Inc.盘中异动 大幅下跌5.20%报27.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518220291?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:03","pubTimestamp":1741615383,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时03分，Beam Therapeutics Inc.股票出现异动，股价急速下跌5.20%。截至发稿，该股报27.00美元/股，成交量237.165万股，换手率2.83%，振幅3.72%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022030396403e21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022030396403e21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4611","BK4556","BK4588","BK4139","BEAM","BK4535","BK4585","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517200169","title":"Beam Therapeutics Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517200169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517200169?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271528,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，Beam Therapeutics Inc.股票出现异动，股价大幅下挫5.09%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Plus Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为953.51%、104.36%、48.88%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208a2628fde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208a2628fde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4588","BK4535","BEAM","BK4556","BK4139","BK4505","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516670089","title":"Beam Therapeutics Inc.盘中异动 早盘急速下挫5.18%报23.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516670089?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:52","pubTimestamp":1741099972,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时52分，Beam Therapeutics Inc.股票出现异动，股价大幅跳水5.18%。截至发稿，该股报23.80美元/股，成交量20.2093万股，换手率0.24%，振幅2.47%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225252abe7f683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225252abe7f683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BEAM","BK4556","LENZ","BK4585","BK4588","BK4535","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516619511","title":"数据：在PEPE、BEAM等代币上损失千万美元的巨鲸转向购买BTC和MKR","url":"https://stock-news.laohu8.com/highlight/detail?id=2516619511","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516619511?lang=zh_cn&edition=full","pubTime":"2025-03-04 12:42","pubTimestamp":1741063374,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"jinse_live","url":"https://x.com/OnchainLens/status/1896779398776512797","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1896779398776512797","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4556","BK4585","ETH.USD.HKCC","BK4588","ETH","MKR.USD.HKCC","BK4601","BK4505","BK4535","BTC.USD.HKCC","BEAM","MKR.USD.CC","BTC","BK4139","XBTmain","BTCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516663938","title":"Beam Therapeutics Inc.盘中异动 下午盘股价大跌5.13%报24.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516663938?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:28","pubTimestamp":1741033681,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时28分，Beam Therapeutics Inc.股票出现波动，股价大幅跳水5.13%。截至发稿，该股报24.99美元/股，成交量81.582万股，换手率0.97%，振幅6.47%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042801abe695f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042801abe695f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BEAM","BK4535","BK4588","BK4585","BK4556","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516786035","title":"某巨鲸以1.17美元均价增持534万枚ONDO，曾投资PEPE及BEAM亏损超1400万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516786035","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516786035?lang=zh_cn&edition=full","pubTime":"2025-03-03 10:58","pubTimestamp":1740970730,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"jinse_live","url":"https://x.com/OnchainLens/status/1896388254917955585","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1896388254917955585","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4505","BK4556","BK4585","BK4535","MKR.USD.HKCC","BEAM","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516341379","title":"Beam Therapeutics Inc.2024财年实现净利润-3.77亿美元，同比减少183.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516341379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516341379?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:01","pubTimestamp":1740758461,"startTime":"0","endTime":"0","summary":"3月1日，Beam Therapeutics Inc.公布财报，公告显示公司2024财年净利润为-3.77亿美元，同比减少183.46%；其中营业收入为63.52百万美元，同比减少83.20%，每股基本收益为-4.58美元。从资产负债表来看，Beam Therapeutics Inc.总负债3.70亿美元，其中短期债务13.47百万美元，资产负债比为2.99，流动比率为4.83。机构评级：截至2025年3月1日，当前有14家机构对Beam Therapeutics Inc.目标价做出预测，其中目标均价为48.43美元，其中最低目标价为24.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000154a258185b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000154a258185b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BEAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514186503","title":"Beam Therapeutics Inc.盘中异动 大幅下跌5.06%报28.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514186503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514186503?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:57","pubTimestamp":1740592630,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时57分，Beam Therapeutics Inc.股票出现异动，股价急速下挫5.06%。截至发稿，该股报28.33美元/股，成交量52.8583万股，换手率0.63%，振幅5.50%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270157109893d107&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270157109893d107&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BEAM","BK4556","LENZ","BK4585","BK4588","BK4535","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166657736","title":"Beam Therapeutics 2024年第四季度GAAP每股收益$(1.09)好于预期$(1.18)，截至第四季度末持有8.507亿美元现金及有价证券，预计运营资金可支撑至2027年","url":"https://stock-news.laohu8.com/highlight/detail?id=1166657736","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166657736?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:39","pubTimestamp":1740487180,"startTime":"0","endTime":"0","summary":"Beam Therapeutics报告季度每股亏损$，好于分析师预期的$，超出预期7.63%。相比去年同期盈余的$1.73，这一数字下降了163.01%。以上内容来自Benzinga Earnings专栏，原文如下：Beam $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 7.63 percent. This is a 163.01 percent decrease over earnings of $1.73 per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BEAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513899211","title":"Beam Therapeutics Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513899211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513899211?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:07","pubTimestamp":1740164828,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时07分，Beam Therapeutics Inc.股票出现异动，股价快速下跌5.07%。截至发稿，该股报31.46美元/股，成交量84.827万股，换手率1.02%，振幅7.39%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030709abd7e75f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030709abd7e75f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BEAM","BK4556","BK4588","BK4535","BK4505","LENZ","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165058","title":"Beam Therapeutics Inc.盘中异动 早盘大幅上涨5.03%报34.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165058?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889142,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Beam Therapeutics Inc.股票出现波动，股价大幅拉升5.03%。截至发稿，该股报34.03美元/股，成交量5.7035万股，换手率0.07%，振幅1.33%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232229889fcc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232229889fcc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BEAM","BK4556","LENZ","BK4585","BK4588","BK4535","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511913026","title":"Beam Therapeutics Inc.盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511913026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511913026?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:35","pubTimestamp":1739543713,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时35分，Beam Therapeutics Inc.股票出现异动，股价大幅上涨5.10%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1116.01%、376.90%、348.40%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virpax Pharmaceuticals, Inc.，振幅分别为23.62%、20.20%、19.73%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223513a24601f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223513a24601f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4556","BK4585","BK4535","BEAM","LENZ","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190923946","title":"AI医疗股美股盘前大涨，Recursion涨12%，木头姐押注AI医药革命","url":"https://stock-news.laohu8.com/highlight/detail?id=1190923946","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190923946?lang=zh_cn&edition=full","pubTime":"2025-02-06 18:38","pubTimestamp":1738838298,"startTime":"0","endTime":"0","summary":"AI医疗股美股盘前大涨， $Recursion Pharmaceuticals, Inc.$涨12%， $CRISPR Therapeutics AG$涨近3%， $Tempus AI$ 涨超3%， $Beam Therapeutics, Inc.$涨7%。其中，在多组学测序方面，报告指出，在海量多组学数据的支持下，结合可编程生物学的驱动，运行自主实验室的AI系统可能会显著降低药物研发全流程的成本，从而改变这个长期停滞的制药行业的回报状况。当前，木头姐的Ark Invest的投资组合中的AI医药股包括RXRX、CRSP、TEM、TWST和BEAM等前景看好的医疗保健股票。","market":"us","thumbnail":"https://static.tigerbbs.com/c5f6cd84096ca9b3b893fb788b76d134","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c5f6cd84096ca9b3b893fb788b76d134"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"AI医疗股大涨，木头姐押注AI医药革命","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","RXRX","BEAM","CRSP"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2509528001","title":"Beam Therapeutics Inc.盘中异动 早盘股价大涨5.20%报27.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509528001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509528001?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:24","pubTimestamp":1738769081,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时24分，Beam Therapeutics Inc.股票出现波动，股价急速上涨5.20%。截至发稿，该股报27.09美元/股，成交量14.1672万股，换手率0.17%，振幅4.17%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.35%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205232441abc3893b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205232441abc3893b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BEAM","BK4588","LENZ","BK4505","BK4585","BK4139","BK4556"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beamtx.com","stockEarnings":[{"period":"1week","weight":0.0473},{"period":"1month","weight":-0.1512},{"period":"3month","weight":-0.2392},{"period":"6month","weight":0.0926},{"period":"1year","weight":0.0387},{"period":"ytd","weight":-0.0887}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0544},{"period":"6month","weight":0.1776},{"period":"1year","weight":0.1654},{"period":"ytd","weight":0.1343}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Beam Therapeutics Inc.成立于2017年1月25日，是一家生物技术公司，致力于根据其专有的碱基编辑技术创建一类新型的精密基因药物，其愿景是为患有严重疾病的患者提供终身治疗疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.016429},{"month":2,"riseRate":0.666667,"avgChangeRate":0.107924},{"month":3,"riseRate":0,"avgChangeRate":-0.199132},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.070856},{"month":5,"riseRate":0.571429,"avgChangeRate":0.076367},{"month":6,"riseRate":0.857143,"avgChangeRate":0.13469},{"month":7,"riseRate":0.428571,"avgChangeRate":0.035999},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.007384},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.009274},{"month":10,"riseRate":0.5,"avgChangeRate":0.022792},{"month":11,"riseRate":0.833333,"avgChangeRate":0.165588},{"month":12,"riseRate":0.5,"avgChangeRate":0.076029}],"exchange":"NASDAQ","name":"Beam Therapeutics, Inc.","nameEN":"Beam Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Beam Therapeutics, Inc.(BEAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Beam Therapeutics, Inc.,BEAM,Beam Therapeutics, Inc.股票,Beam Therapeutics, Inc.股票老虎,Beam Therapeutics, Inc.股票老虎国际,Beam Therapeutics, Inc.行情,Beam Therapeutics, Inc.股票行情,Beam Therapeutics, Inc.股价,Beam Therapeutics, Inc.股市,Beam Therapeutics, Inc.股票价格,Beam Therapeutics, Inc.股票交易,Beam Therapeutics, Inc.股票购买,Beam Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Beam Therapeutics, Inc.(BEAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}